2m 2m 2m 2m 2m 2m 2m
LIPOCINE (LPCN)
NASDAQ
$1.58-$0.02 (-0.94%)
Price as of Nov 12, 2026 9:54 AM EST- $17.6MMarket Cap
- -45.55%1-Year Change
- BiotechnologyIndustry
LIPOCINE (LPCN)
$1.58-$0.02 (-0.94%)
LPCN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.59 | ||
Change | $0.00 (0.00%) | ||
Open | $1.62 | ||
High | $1.64 | ||
Low | $1.56 | ||
Previous Close | $1.59 | ||
Volume | 208,114 | ||
30-Day Average Volume | 283,703 | ||
1-Week Change | 10.42% | ||
1-Month Change | -7.56% | ||
1-Year Change | -45.55% | ||
3-Year Change | -36.40% | ||
5-Year Change | -92.07% | ||
Fundamentals | |||
Shares Outstanding | 11.1M | ||
Total Assets | $23.2M | ||
Market Cap | $17.6M | ||
Enterprise Value | $15.0M | ||
Period: QTR TTM FY | |||
Revenue | $2.3M | ||
Net Income | -$679,350.00 | ||
Free Cash Flow | -$1.8M | ||
EBIT | -$679,350.00 | ||
EBITDA | -$664,703.00 | ||
Net Working Capital | $21.1M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 1 | ||
P/E | -20 | ||
PEG | -0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 17 | ||
Last Split Date | 05/12/2023 | ||
Earnings & Revenue